ACQUISITIONS AND DISPOSITIONS (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jul. 25, 2024 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Discontinued operations | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Scienture Inc [Member] | ||||||
| Purchase price consideration | $ 78,646,184 | |||||
| Common stock price per share | $ 11.63 | |||||
| Common Stock [Member] | ||||||
| Issuance of shares pursuant to Merger | 7,103,614 | |||||
| Merger Agreement [Member] | Scienture Inc [Member] | Series X Preferred Stock [Member] | ||||||
| Issuance of shares pursuant to Merger | 6,826,753 | |||||
| Merger Agreement [Member] | Common Stock [Member] | Scienture Inc [Member] | ||||||
| Issuance of shares pursuant to Merger | 291,536 | |||||
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity attributable to discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|